Real-World Study on the Burden of Hidradenitis Suppurativa

PeriPharm

Status: Not yet enrolling

Conditions: Hidradenitis Suppurativa (HS)

Treatments: Other: No Intervention: Observational Cohort

Study type: Observational

Funder types: Other

Identifiers

NCT07323303

PROxy85HS

Details and patient eligibility

About

Despite the significant impact of HS on patients' quality of life (QoL) and daily functioning, there remains limited real-world evidence describing the burden of this condition in Canada. HS is an under-recognized and often misdiagnosed condition, with a substantial psychological and physical burden on patients. Understanding the real-world experiences of individuals living with HS in Canada can help identify unmet needs and inform patient-centered care approaches.

Enrollment: 100 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Patient diagnosed with HS;
2. Aged ≥18 years;
3. Able to read and understand French or English;
4. Willing and able to provide written informed consent.

Exclusion criteria

1. Participation in an interventional study for HS.

Trial design

100 participants in 1 patient group

Patient with HS

Description:

Patient diagnosed with HS

Treatment:

Other: No Intervention: Observational Cohort